Corporate News 21-Jan-22
Laurus Labs to manufacture oral Covid-19 antiviral medication
Laurus Labs has signed an agreement with MPP ( Medicine Patient Pool) for the manufacturing of the oral COVID-19 antiviral medication Molnupiravir.
Previous News
Laurus Labs Ltd gains for third straight session
( Hot Pursuit - 06-Nov-23 13:05 )
Laurus Labs slips after US FDA issues Form 483 with five observations to Parawada facility
( Hot Pursuit - 13-Dec-23 09:39 )
Laurus Labs fixes record date for 2nd interim dividend
( Market Beat - Reports 27-Apr-23 15:18 )
Laurus Labs Ltd up for third consecutive session
( Hot Pursuit - 02-Jul-24 13:05 )
Laurus Labs
( Results - Analysis 24-Jan-24 17:06 )
Laurus Labs allots 2.83 lakh equity shares under ESOS
( Corporate News - 09-Dec-23 12:09 )
Laurus Labs announces board meeting date
( Corporate News - 20-Jan-22 12:41 )
Laurus Labs to conduct board meeting
( Corporate News - 18-Apr-24 12:39 )
Volumes soar at New India Assurance Company Ltd counter
( Hot Pursuit - 29-Nov-22 11:00 )
Laurus Labs Ltd up for third straight session
( Hot Pursuit - 14-Nov-22 13:05 )
Laurus Labs consolidated net profit declines 55.32% in the March 2023 quarter
( Results - Announcements 27-Apr-23 16:01 )
Other Stories
Tridhya Tech to convene board meeting
03-Jul-24 20:06
Sonu Infratech schedules EGM
03-Jul-24 19:59
Sakuma Exports to convene AGM
03-Jul-24 19:59
Time Technoplast repays commercial paper
03-Jul-24 18:31
Board of Aditya Vision approves stock split and listing of share on NSE
03-Jul-24 18:24
Pricol director resigns
03-Jul-24 18:21
Board of VMS Industries recommends first interim dividend
03-Jul-24 17:49
Lakshmi Machine Works to declare Quarterly Result
03-Jul-24 17:44
Modison to convene AGM
03-Jul-24 17:43
Sybly Industries to discuss results
03-Jul-24 17:43
Back
Top
